Heart Transplant: Candidates, Procedure, and Life After Surgery

A heart transplant is a major treatment option for selected people with end-stage heart failure when other medical, device-based, or surgical treatments are no longer enough. Careful evaluation, expert surgery, lifelong follow-up, and daily self-care all help protect the donated heart and support recovery.

Overview

A heart transplant is an operation in which a failing heart is replaced with a healthy donor heart. It is usually considered for people with end-stage heart failure, a condition in which the heart can no longer pump enough blood to meet the body’s needs despite advanced medical care. The goal is to improve survival, function, and quality of life for carefully selected patients.

Heart transplantation is not the first treatment for heart disease. Before it is considered, doctors usually try a combination of medicines, lifestyle measures, implantable devices, procedures to restore blood flow, valve surgery, rhythm treatment, or mechanical circulatory support when appropriate. Transplant becomes a possible option when these treatments are no longer effective or suitable.

The process involves much more than the surgery itself. It includes a comprehensive evaluation, time on a waiting list, donor matching, the transplant operation, hospital recovery, rehabilitation, and lifelong follow-up. Because the immune system can recognize the donated heart as foreign, patients must take immunosuppressive medicines every day after transplant to reduce the risk of rejection.

Who May Be a Candidate for Heart Transplant?

Heart transplant candidates are typically people with advanced heart failure who have severe symptoms, frequent hospitalizations, or life-limiting heart disease despite optimized treatment. Common reasons may include cardiomyopathy, severe coronary artery disease that cannot be corrected by other procedures, certain congenital heart conditions, or advanced valve-related heart failure. Some patients are assessed after temporary or long-term mechanical support, such as a ventricular assist device.

Eligibility depends on both need and safety. A transplant team evaluates whether the person is likely to benefit from surgery and whether other organs, such as the kidneys, liver, lungs, and brain, can tolerate the procedure and long-term medication. Age alone is not the only factor; overall health, frailty, other illnesses, and the ability to participate in care are all important.

Factors that may make transplant unsuitable or require treatment before listing include an active serious infection, active cancer, severe irreversible disease in other organs, uncontrolled pulmonary hypertension, ongoing substance misuse, or inability to take medicines reliably. Some issues are temporary and can be addressed, while others may lead the team to recommend another form of care.

Psychological and social readiness are also part of candidacy. Patients need to understand the demands of transplant care, attend follow-up visits, manage medicines, monitor symptoms, and have support during recovery. This assessment is not meant to exclude people unfairly, but to help ensure the safest possible outcome for each patient.

Evaluation and Waiting List Process

The transplant evaluation is detailed and may take place over days or weeks, depending on urgency. It usually includes blood tests, imaging, heart catheterization, lung function testing, kidney and liver assessment, infection screening, cancer screening, dental evaluation, and assessment of nutritional status. Doctors also review previous surgeries, allergies, current medicines, and the cause of heart failure.

Blood type, body size, immune system markers, and medical urgency help determine donor matching. Patients may also be tested for antibodies that could increase the chance of rejection. The team explains what it means to be placed on the waiting list, how donor offers are reviewed, and what the patient should do if a suitable heart becomes available.

While waiting, patients continue heart failure treatment and monitoring. Some may remain at home with close follow-up, while others may need hospital care, intravenous medicines, or mechanical circulatory support. The care team may recommend vaccines, nutrition support, physical conditioning as tolerated, and treatment of infections or dental problems before surgery.

Waiting can be emotionally challenging. Patients and families are encouraged to ask questions, maintain communication with the transplant coordinator, and prepare practical plans for travel to the hospital when called. A donor heart offer can come at any time, and the final decision to proceed depends on donor heart quality, matching, and the patient’s condition at that moment.

The Heart Transplant Procedure

When a donor heart is accepted, the patient is admitted and prepared for surgery. The team confirms medical stability, repeats key tests, reviews consent, and starts medications as needed. The operation is performed under general anesthesia, meaning the patient is asleep and does not feel pain during the procedure.

During the surgery, the chest is opened through the breastbone, and a heart-lung machine temporarily takes over circulation and oxygenation. The surgeon removes the failing heart while preserving important structures, then connects the donor heart to the major blood vessels. Once blood flow is restored, the new heart is carefully monitored as it begins to work in the recipient’s body.

The length and complexity of the operation vary depending on the patient’s condition, previous surgeries, anatomy, and whether a ventricular assist device or other support is present. After surgery, the patient is moved to an intensive care unit. Breathing support, drains, monitoring lines, and intravenous medicines are commonly used during the early recovery period.

In the first days after transplant, doctors watch closely for bleeding, rhythm problems, early graft function, kidney function, infection, and signs of rejection. As the patient stabilizes, breathing support and lines are removed, physical activity begins gradually, and education about medicines and warning signs becomes a central part of care.

Recovery in the Hospital and at Home

Hospital recovery after heart transplant is highly individualized. Many patients spend time in intensive care and then transfer to a transplant ward for continued monitoring, rehabilitation, and medication adjustment. The team checks laboratory results, heart function, wound healing, fluid balance, and response to immunosuppressive medicines.

Before discharge, patients and caregivers receive detailed instructions. These usually include how and when to take medicines, how to measure temperature, blood pressure, pulse, and weight, how to care for the surgical wound, and when to call the transplant team. Medication schedules can be complex at first, so written plans, pill organizers, and support from family members are often helpful.

At home, recovery continues gradually. Walking, breathing exercises, and supervised cardiac rehabilitation may help restore strength and confidence. Heavy lifting and strenuous activity are restricted until the breastbone and tissues heal. Patients should follow the activity plan provided by their transplant team, because recovery speed differs from person to person.

Emotional adjustment is also part of recovery. It is common to feel relief, gratitude, anxiety, or uncertainty at different times. Support from transplant nurses, psychologists, social workers, rehabilitation specialists, and patient support groups can help patients and families adapt to the new routines of life after surgery.

Rejection, Medicines, and Follow-up Care

Rejection occurs when the immune system attacks the transplanted heart. Immunosuppressive medicines lower this risk, but they must be taken exactly as prescribed and usually continue for life. Stopping or missing doses can be dangerous, even if the patient feels well, because rejection may not cause symptoms in its early stages.

Follow-up care is designed to detect problems early. Depending on the transplant center’s protocol and the patient’s stage of recovery, monitoring may include clinic visits, blood tests, electrocardiograms, echocardiograms, heart biopsies, imaging tests, and assessment of medicine levels. Over time, visits may become less frequent, but long-term follow-up remains essential.

Immunosuppressive medicines can have side effects, including increased infection risk, kidney strain, high blood pressure, diabetes, cholesterol changes, tremor, bone thinning, or effects on the skin. The transplant team adjusts treatment to balance rejection prevention with side effect management. Patients should not start over-the-counter medicines, herbal products, or supplements without checking with their doctor, because interactions can be significant.

Patients are also monitored for transplant-related coronary artery disease, sometimes called cardiac allograft vasculopathy, which can develop over time in the donor heart. Because nerves are affected during transplant, chest pain may not occur in the usual way. Regular testing and prompt reporting of fatigue, shortness of breath, swelling, palpitations, fever, or reduced exercise tolerance are important.

Life After Heart Transplant: Prevention and Self-care

Life after heart transplant is built around consistent daily habits. Taking medicines on time, attending follow-up appointments, and reporting changes early are the most important self-care steps. Patients are often encouraged to keep a health diary with medicine times, weight, blood pressure, pulse, temperature, symptoms, and questions for the care team.

Infection prevention is especially important because immunosuppressive medicines weaken some immune defenses. Patients should practice careful hand hygiene, follow food safety guidance, avoid close contact with people who have contagious illnesses, and discuss vaccines with the transplant team. Live vaccines may not be suitable for many transplant recipients, so vaccination planning should always be individualized by a doctor.

Healthy lifestyle choices help protect the transplanted heart and overall health. A heart-healthy eating pattern, safe physical activity, tobacco avoidance, limited or avoided alcohol as advised, good sleep, stress management, sun protection, dental care, and regular cancer screening may all be recommended. The transplant team can provide guidance tailored to the patient’s medicines, kidney function, weight, blood sugar, and blood pressure.

International patients may need extra planning for follow-up care, medicine supply, travel timing, and communication between local doctors and the transplant center. Near the end of the care pathway, Acibadem International can support patients through multidisciplinary specialists and JCI-accredited hospitals that diagnose and treat heart transplant-related conditions for international patients, in coordination with appropriate long-term medical follow-up.

When to See a Doctor

Patients with advanced heart failure should speak with a cardiologist if symptoms continue despite treatment, especially if daily activities are limited, hospital admissions are becoming frequent, or medicines are no longer controlling fluid buildup or breathlessness. A heart failure specialist can assess whether advanced therapies, including transplant evaluation, may be appropriate.

After transplant, patients should contact their transplant team promptly if they develop fever, chills, increasing shortness of breath, sudden weight gain, swelling, dizziness, fainting, new palpitations, wound redness or drainage, vomiting that prevents taking medicines, or unusual fatigue. These symptoms do not always mean rejection, but they should be assessed without delay.

Emergency care is needed for severe breathing difficulty, chest pressure, confusion, collapse, uncontrolled bleeding, or signs of stroke such as facial drooping, arm weakness, or speech difficulty. Patients should carry transplant identification and an updated medicine list, so any medical team can understand their transplant status and current treatment.

Frequently asked questions

Who is considered for a heart transplant?

Heart transplant may be considered for people with end-stage heart failure when symptoms remain severe despite optimized medicines, devices, or other procedures. A transplant team evaluates heart disease severity, other organ function, infection and cancer risk, and the patient’s ability to follow lifelong care. Not everyone with heart failure needs or qualifies for transplant.

How long does it take to get a donor heart?

Waiting time varies widely and cannot be predicted for an individual patient. It depends on blood type, body size, immune matching, medical urgency, donor availability, and local allocation rules. Some patients wait at home, while others need hospital care or mechanical circulatory support while waiting.

Is heart transplant surgery painful?

The operation is performed under general anesthesia, so the patient does not feel pain during surgery. Afterward, discomfort around the chest incision is expected and is managed with appropriate pain control. Pain usually improves gradually as healing progresses, but any worsening or unusual pain should be reported.

What medicines are needed after a heart transplant?

Patients need immunosuppressive medicines to reduce the risk of rejection, usually for the rest of their lives. They may also need medicines to prevent infection, control blood pressure, manage cholesterol, protect the stomach or bones, or treat other conditions. The exact plan is individualized and should never be changed without the transplant team’s guidance.

Can a person live a normal life after a heart transplant?

Many people return to meaningful daily activities, work, travel, exercise, and family life after recovery, but they must maintain lifelong medical follow-up. Daily medicines, infection precautions, regular testing, and healthy habits remain essential. The goal is not only to recover from surgery, but to protect the donor heart over time.

What are the signs of rejection after heart transplant?

Rejection may cause fatigue, shortness of breath, swelling, weight gain, palpitations, low-grade fever, or reduced exercise tolerance, but it can also occur with few or no symptoms. This is why scheduled tests and clinic visits are so important. Patients should contact their transplant team if they notice new or concerning changes.

Can heart transplant recipients travel internationally?

International travel may be possible once the transplant team confirms that recovery is stable and follow-up needs can be managed. Patients should plan medicine supply, infection precautions, travel insurance considerations, and access to medical care at the destination. They should carry a transplant summary and current medicine list when traveling.

References

• International Society for Heart and Lung Transplantation
• American Heart Association
• National Heart, Lung, and Blood Institute
• European Society of Cardiology
• Mayo Clinic

This article is for general information only and is not a substitute for professional medical advice. Please consult a qualified doctor about your individual situation.